Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.66 USD
2.46 B USD
7.45 B USD
613.32 M
About CHUGAI PHARMACEUTICAL CO
Sector
Industry
CEO
Osamu Okuda
Website
Headquarters
Tokyo
Founded
1925
ISIN
JP3519400000
FIGI
BBG000C0DYR7
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
4519:TSE - CHUGAI PHARMACEUTICAL - Up 145% over 12 months.Japanese listed Chugai Pharmaceutical is in a nice steady up trend. Could be worth a watch.
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business
4519, Chugai Pharmaceutical Co. - Breakout on ascending triangleTSE:4519
Net breakout of the resistance of this ascending triangle.
As always, one of the parameters for deciding whether or not to enter our trade is the Yield Risk ratio, in which winning trades allow us both to compensate for the small losses we make 60% of the time and to create that extra marg
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of CHGCF is 51.58 USD — it has decreased by −0.52% in the past 24 hours. Watch Chugai Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Chugai Pharmaceutical Co., Ltd. stocks are traded under the ticker CHGCF.
CHGCF stock has fallen by −1.77% compared to the previous week, the month change is a −13.02% fall, over the last year Chugai Pharmaceutical Co., Ltd. has showed a 73.38% increase.
We've gathered analysts' opinions on Chugai Pharmaceutical Co., Ltd. future price: according to them, CHGCF price has a max estimate of 83.30 USD and a min estimate of 43.73 USD. Watch CHGCF chart and read a more detailed Chugai Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Chugai Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
CHGCF reached its all-time high on May 27, 2020 with the price of 125.00 USD, and its all-time low was 8.05 USD and was reached on Oct 31, 2002. View more price dynamics on CHGCF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CHGCF stock is 0.53% volatile and has beta coefficient of 1.02. Track Chugai Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Chugai Pharmaceutical Co., Ltd. there?
Today Chugai Pharmaceutical Co., Ltd. has the market capitalization of 86.52 B, it has decreased by −0.46% over the last week.
Yes, you can track Chugai Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Chugai Pharmaceutical Co., Ltd. is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
CHGCF earnings for the last quarter are 0.39 USD per share, whereas the estimation was 0.34 USD resulting in a 15.94% surprise. The estimated earnings for the next quarter are 0.49 USD per share. See more details about Chugai Pharmaceutical Co., Ltd. earnings.
Chugai Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 1.92 B USD, despite the estimated figure of 1.77 B USD. In the next quarter, revenue is expected to reach 2.23 B USD.
CHGCF net income for the last quarter is 648.16 M USD, while the quarter before that showed 582.32 M USD of net income which accounts for 11.31% change. Track more Chugai Pharmaceutical Co., Ltd. financial stats to get the full picture.
Chugai Pharmaceutical Co., Ltd. dividend yield was 1.40% in 2024, and payout ratio reached 41.63%. The year before the numbers were 1.50% and 40.44% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 10, 2025, the company has 7.78 K employees. See our rating of the largest employees — is Chugai Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Chugai Pharmaceutical Co., Ltd. EBITDA is 3.90 B USD, and current EBITDA margin is 49.17%. See more stats in Chugai Pharmaceutical Co., Ltd. financial statements.
Like other stocks, CHGCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Chugai Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Chugai Pharmaceutical Co., Ltd. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Chugai Pharmaceutical Co., Ltd. stock shows the buy signal. See more of Chugai Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.